CD8A and neoplasm: In contrast to M2-like macrophages, a high density of dendritic cells (DCs) at the tumor site may be beneficial because of their ability to present extracellular antigens on major histocompatibility complex (MHC-I) class I molecules to enable antitumor CD8+ T cell activation [49].